S&P 500

6.032,38

0,56%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Boundless Bio Inc (BOLD)
Boundless Bio Inc (BOLD) Notícias

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:BOLD

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
25/11/2024	09:00	GlobeNewswire Inc.	Boundless Bio to Participate in the Piper Sandler Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc
07/11/2024	18:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BOLD	Boundless Bio Inc
07/11/2024	18:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLD	Boundless Bio Inc
07/11/2024	18:01	GlobeNewswire Inc.	Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights	NASDAQ:BOLD	Boundless Bio Inc
05/11/2024	09:00	GlobeNewswire Inc.	Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc
14/10/2024	09:00	GlobeNewswire Inc.	Boundless Bio Announces Departure of Chief Financial Officer	NASDAQ:BOLD	Boundless Bio Inc
11/09/2024	08:00	GlobeNewswire Inc.	Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc
20/08/2024	20:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BOLD	Boundless Bio Inc
12/08/2024	17:01	GlobeNewswire Inc.	Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results	NASDAQ:BOLD	Boundless Bio Inc
05/06/2024	08:00	Business Wire	Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc
13/05/2024	08:00	Business Wire	Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights	NASDAQ:BOLD	Boundless Bio Inc
06/05/2024	09:00	Business Wire	Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024	NASDAQ:BOLD	Boundless Bio Inc
11/04/2024	09:00	Business Wire	Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications	NASDAQ:BOLD	Boundless Bio Inc
08/04/2024	09:00	Business Wire	Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024	NASDAQ:BOLD	Boundless Bio Inc
14/02/2020	19:23	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
11/02/2020	18:41	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BOLD	Boundless Bio Inc
27/01/2020	11:38	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:BOLD	Boundless Bio Inc
21/01/2020	08:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BOLD	Boundless Bio Inc
03/12/2019	21:13	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.	NASDAQ:BOLD	Boundless Bio Inc
02/12/2019	20:01	Business Wire	Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics	NASDAQ:BOLD	Boundless Bio Inc
26/11/2019	18:01	Business Wire	Audentes Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:BOLD	Boundless Bio Inc
12/11/2019	19:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
07/11/2019	19:18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BOLD	Boundless Bio Inc
07/11/2019	18:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
07/11/2019	18:01	Business Wire	Audentes Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:BOLD	Boundless Bio Inc
31/10/2019	08:00	Business Wire	Audentes Therapeutics to Release Third Quarter 2019 Financial Results and Provide Corporate Update on Thursday, November 7, 2...	NASDAQ:BOLD	Boundless Bio Inc
05/10/2019	08:01	Business Wire	Audentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked M...	NASDAQ:BOLD	Boundless Bio Inc
04/10/2019	19:00	Business Wire	Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:BOLD	Boundless Bio Inc
30/09/2019	09:00	Business Wire	Audentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including Ne...	NASDAQ:BOLD	Boundless Bio Inc
23/08/2019	17:03	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:BOLD	Boundless Bio Inc